+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pharmaceutical Thickener Excipients Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6277823
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Pharmaceutical Thickener Excipients: Executive Overview

Pharmaceutical thickener excipients are inactive ingredients used to increase viscosity, stabilize dispersed systems, improve mouthfeel, support suspension uniformity, and control the handling characteristics of oral, topical, ophthalmic, and other dosage forms. Their selection is shaped by route of administration, formulation performance, safety requirements, manufacturing conditions, regulatory status, and compatibility with active ingredients and packaging.

The market is influenced by the expansion of patient-friendly dosage forms, greater attention to formulation robustness, demand for reliable supply, and the need to meet increasingly specific quality and documentation expectations. Natural polymers, cellulose derivatives, synthetic polymers, and mineral-based materials each offer distinct functionality, requiring formulators to balance performance, processability, patient acceptability, and supply-chain resilience.

Formulation Complexity and Supply Resilience Are Reshaping Excipient Selection

Formulators are increasingly evaluating thickeners as multifunctional excipients rather than isolated viscosity-building agents. A single material may contribute to suspension stability, texture, mucoadhesion, film formation, controlled release, or improved pourability. This broadens the technical assessment beyond viscosity measurements to include rheological behavior, hydration kinetics, ionic sensitivity, microbial control, compatibility, and performance across storage conditions.

The landscape is also shifting toward stronger supply-chain qualification. Variability in botanical inputs, specialized manufacturing capacity, transportation conditions, and regional regulatory documentation can affect continuity and batch consistency. Consequently, pharmaceutical organizations are placing greater emphasis on dual sourcing, supplier audits, change-control transparency, traceability, and analytical comparability when qualifying thickener excipients.

Artificial Intelligence Accelerates Excipient Screening and Process Control

Artificial intelligence can support pharmaceutical thickener development by connecting formulation composition, processing conditions, rheological profiles, stability results, and historical batch data. Machine-learning models may help identify promising excipient combinations, predict viscosity behavior, prioritize compatibility studies, and reduce experimental cycles during early development.

In manufacturing, AI-enabled monitoring can assist with detecting abnormal mixing behavior, hydration deviations, raw-material variability, and emerging process drift. Its value depends on well-curated datasets, validated analytical methods, explainable model outputs, and appropriate human oversight. AI should complement-not replace-laboratory confirmation, quality risk management, regulatory evaluation, and documented process validation.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America emphasizes stringent quality systems, reproducible performance, advanced dosage-form development, and detailed supplier qualification. Europe combines mature pharmaceutical manufacturing with strong attention to excipient functionality, sustainability, pharmacopoeial compliance, and lifecycle documentation. Asia-Pacific presents extensive formulation and manufacturing activity, alongside diverse regulatory environments and growing demand for robust local and international supply networks.

Latin America is shaped by the need for dependable access, adaptable formulation strategies, and regulatory alignment across varied national systems. The Middle East places importance on import reliability, quality documentation, and manufacturing localization in selected jurisdictions. Africa’s priorities include affordability, storage resilience, supply continuity, and dosage forms suited to differing healthcare and distribution conditions. Across all regions, local regulatory expectations and climate-related stability considerations remain central to excipient selection.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Reflect Distinct Coordination Needs

ASEAN markets require navigation of varied national requirements while benefiting from regional manufacturing linkages and expanding pharmaceutical capabilities. BRICS economies combine substantial production and patient-access priorities with differences in regulatory maturity, domestic sourcing, and technical standards. The European Union supports harmonized regulatory principles while retaining complex expectations for quality, documentation, sustainability, and cross-border supply.

G7 countries generally emphasize advanced quality management, innovation, traceability, and sophisticated formulation development. GCC markets focus on dependable imports, registration readiness, climate-appropriate stability, and growing interest in regional pharmaceutical capacity. NATO members are not a single regulatory or commercial market, but their overlapping emphasis on resilience, continuity planning, and critical-supply preparedness can influence excipient procurement and inventory strategies.

Country-Level Priorities Span Advanced Development, Manufacturing Scale, and Access Requirements

Australia combines stringent therapeutic-product expectations with geographic supply-chain considerations. Brazil and Mexico require attention to national registration processes, local manufacturing contexts, and distribution complexity. Canada and the United States emphasize rigorous quality systems, supplier qualification, and formulation innovation. China and India combine large pharmaceutical manufacturing ecosystems with strong interest in production efficiency, domestic capability, and regulatory modernization.

France, Germany, Italy, Spain, and the United Kingdom place substantial weight on documented quality, pharmacopoeial alignment, sustainability, and reliable cross-border supply. Japan and South Korea emphasize high manufacturing precision, advanced dosage-form development, and consistency. Russia presents a distinct environment shaped by supply continuity, regulatory adaptation, and sourcing considerations. Across these countries, successful excipient strategies require locally informed regulatory assessment, technical documentation, and contingency planning.

Prioritize Functional Qualification, Dual Sourcing, and Data-Driven Development

Industry leaders should define excipient requirements through measurable critical material attributes and link them to critical quality attributes for each dosage form. Qualification programs should assess rheology, hydration, compatibility, microbial quality, impurity profiles, stability, process sensitivity, and patient-use characteristics rather than relying on a single viscosity value.

Organizations should strengthen resilience through qualified alternate suppliers, regional inventory strategies, transparent change-control agreements, and periodic requalification. Development teams can improve efficiency by combining design-of-experiments approaches with structured historical data and carefully validated AI tools. Regulatory teams should maintain current compendial, safety, allergen, origin, and documentation assessments, while procurement and technical functions should jointly evaluate total supply risk instead of unit cost alone.

Methodology: Evidence-Based Assessment of Functional, Regulatory, and Supply Factors

This executive summary uses a structured qualitative assessment of pharmaceutical thickener excipients across dosage-form functionality, formulation science, manufacturing practice, regulatory expectations, regional operating conditions, and supply-chain resilience. The analysis distinguishes excipient classes by their technical roles and considers how route of administration, process conditions, storage environment, and patient requirements influence selection.

Regional, group, and country perspectives are synthesized from established pharmaceutical-development principles and observable differences in regulatory coordination, manufacturing capability, healthcare access, logistics, and quality-system expectations. No market estimates, market sizing, market shares, forecasts, or company-specific claims are used. Findings should be validated against current pharmacopeias, national requirements, supplier documentation, and product-specific development data before operational decisions are made.

Reliable Thickener Strategies Depend on Performance Evidence and Resilient Execution

Pharmaceutical thickener excipients are becoming more strategically important as dosage forms grow more complex and manufacturers pursue consistent quality, patient acceptability, and dependable supply. The strongest approaches connect material functionality with product performance, process capability, regulatory readiness, and lifecycle management.

Leaders who combine rigorous characterization, regional awareness, supplier resilience, and responsible use of digital tools can make more informed excipient decisions. Continuous monitoring of raw-material variability, regulatory change, manufacturing performance, and patient-use requirements will remain essential for maintaining robust formulations across diverse markets.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pharmaceutical Thickener Excipients Market, by Chemical Class
7.1. Introduction
7.2. Cellulosic Derivatives
7.2.1. Carboxymethyl Cellulose (CMC)
7.2.2. Hydroxypropyl Cellulose (HPC)
7.2.3. Hydroxypropyl Methylcellulose (HPMC)
7.3. Inorganic Thickeners
7.3.1. Bentonite
7.3.2. Colloidal Silica
7.4. Natural Polysaccharides
7.4.1. Alginate
7.4.2. Guar Gum
7.4.3. Modified Starch
7.4.4. Pectin
7.4.5. Xanthan Gum
7.5. Synthetic Polymers
7.5.1. Carbomers (Polyacrylic Acid)
7.5.2. Polyacrylates
7.5.3. Polyethylene Oxide
8. Pharmaceutical Thickener Excipients Market, by Dosage Form
8.1. Introduction
8.2. Injectable
8.3. Ophthalmic
8.4. Oral Liquid
8.4.1. Emulsions
8.4.2. Suspensions
8.4.3. Syrups
8.5. Topical
8.5.1. Creams
8.5.2. Gels
8.5.3. Ointments
9. Pharmaceutical Thickener Excipients Market, by Form
9.1. Introduction
9.2. Liquid Concentrate
9.3. Powder
9.4. Ready To Use Gel
10. Pharmaceutical Thickener Excipients Market, by Product Grade
10.1. Introduction
10.2. Food Grade
10.3. Pharmaceutical Grade
10.4. Technical Grade
11. Pharmaceutical Thickener Excipients Market, by Application
11.1. Introduction
11.2. Binder
11.3. Controlled Release
11.4. Emulsion Stabilizer
11.5. Suspending Agent
11.6. Viscosity Modification
12. Pharmaceutical Thickener Excipients Market, by Sales Channel
12.1. Introduction
12.2. Contract Supply Partners
12.3. Direct Manufacturer Sales
12.4. Distributor
12.5. E Commerce
13. Pharmaceutical Thickener Excipients Market, by End User
13.1. Introduction
13.2. Branded Manufacturers
13.3. Contract Manufacturing Organizations
13.4. Generic Manufacturers
13.5. Hospital Pharmacies
13.6. Research Institutions
14. Pharmaceutical Thickener Excipients Market, by Region
14.1. Introduction
14.2. Asia-Pacific
14.3. North America
14.4. Latin America
14.5. Europe
14.6. Middle East
14.7. Africa
15. Pharmaceutical Thickener Excipients Market, by Group
15.1. Introduction
15.2. ASEAN
15.3. GCC
15.4. European Union
15.5. BRICS
15.6. G7
15.7. NATO
16. Pharmaceutical Thickener Excipients Market, by Country
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. United Kingdom
16.7. Germany
16.8. France
16.9. Russia
16.10. Italy
16.11. Spain
16.12. China
16.13. India
16.14. Japan
16.15. Australia
16.16. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. Market Concentration Analysis, 2025
17.2.1. Concentration Ratio (CR)
17.2.2. Herfindahl Hirschman Index (HHI)
17.3. Recent Developments & Impact Analysis, 2025
17.4. Product Portfolio Analysis, 2025
17.5. Benchmarking Analysis, 2025
18. Company Profiles
18.1. ABITEC Corporation
18.2. Akzo Nobel N.V.
18.3. Archer Daniels Midland Company
18.4. Ashland Global Holdings Inc.
18.5. Ashland Inc.
18.6. BASF SE
18.7. Clariant AG
18.8. Colorcon Inc.
18.9. CP Kelco
18.10. Croda International Plc
18.11. DFE Pharma GmbH & Co. KG
18.12. DuPont de Nemours, Inc.
18.13. Elementis Plc
18.14. Evonik Industries AG
18.15. Gattefossé SAS
18.16. Ingredion Incorporated
18.17. International Flavors & Fragrances Inc.
18.18. JRS PHARMA GmbH + Co. KG
18.19. Kerry Group P.L.C.
18.20. Merck KGaA
18.21. Roquette Frères S.A.
18.22. Shin-Etsu Chemical Co., Ltd.
18.23. SPI Pharma Inc.
18.24. Sumitomo Seika Chemicals Company, Limited
18.25. The Lubrizol Corporation
19. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pharmaceutical Thickener Excipients Market, Years Considered for the Study
FIGURE 2. Global Pharmaceutical Thickener Excipients Market, Research Design
FIGURE 3. Global Pharmaceutical Thickener Excipients Market, Research Framework
FIGURE 4. Global Pharmaceutical Thickener Excipients Market, Data Triangulation
FIGURE 5. Global Pharmaceutical Thickener Excipients Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2025 vs 2032 (%)
FIGURE 7. Global Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pharmaceutical Thickener Excipients Market Size, by Form, 2025 vs 2032 (%)
FIGURE 11. Global Pharmaceutical Thickener Excipients Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2025 vs 2032 (%)
FIGURE 13. Global Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pharmaceutical Thickener Excipients Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Pharmaceutical Thickener Excipients Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 17. Global Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Pharmaceutical Thickener Excipients Market Size, by End User, 2025 vs 2032 (%)
FIGURE 19. Global Pharmaceutical Thickener Excipients Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Pharmaceutical Thickener Excipients Market Size, by Region, 2025 vs 2032 (%)
FIGURE 21. Global Pharmaceutical Thickener Excipients Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Pharmaceutical Thickener Excipients Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Pharmaceutical Thickener Excipients Market Size, by Country, 2025 vs 2032 (%)
FIGURE 24. Global Pharmaceutical Thickener Excipients Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Pharmaceutical Thickener Excipients Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pharmaceutical Thickener Excipients Market Segmentation & Coverage
TABLE 2. Global Pharmaceutical Thickener Excipients Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 4. Global Cellulosic Derivatives Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cellulosic Derivatives Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cellulosic Derivatives Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Carboxymethyl Cellulose (CMC) Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Carboxymethyl Cellulose (CMC) Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Carboxymethyl Cellulose (CMC) Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Hydroxypropyl Cellulose (HPC) Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Hydroxypropyl Cellulose (HPC) Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Hydroxypropyl Cellulose (HPC) Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Hydroxypropyl Methylcellulose (HPMC) Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Hydroxypropyl Methylcellulose (HPMC) Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Hydroxypropyl Methylcellulose (HPMC) Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Inorganic Thickeners Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Inorganic Thickeners Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Inorganic Thickeners Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Bentonite Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Bentonite Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Bentonite Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Colloidal Silica Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Colloidal Silica Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Colloidal Silica Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Natural Polysaccharides Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Natural Polysaccharides Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Natural Polysaccharides Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Alginate Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Alginate Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Alginate Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Guar Gum Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Guar Gum Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Guar Gum Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Modified Starch Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Modified Starch Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Modified Starch Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Pectin Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Pectin Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Pectin Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Xanthan Gum Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Xanthan Gum Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Xanthan Gum Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Synthetic Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Synthetic Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Synthetic Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Carbomers (Polyacrylic Acid) Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Carbomers (Polyacrylic Acid) Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Carbomers (Polyacrylic Acid) Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Polyacrylates Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Polyacrylates Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Polyacrylates Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Polyethylene Oxide Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Polyethylene Oxide Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Polyethylene Oxide Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 56. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Ophthalmic Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Ophthalmic Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Ophthalmic Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Oral Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Oral Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Oral Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Emulsions Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Emulsions Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Emulsions Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Suspensions Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Suspensions Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Suspensions Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Syrups Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Syrups Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Syrups Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Creams Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Creams Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Creams Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Gels Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Gels Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Gels Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Ointments Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Ointments Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Ointments Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 87. Global Liquid Concentrate Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Liquid Concentrate Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Liquid Concentrate Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Ready To Use Gel Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Ready To Use Gel Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Ready To Use Gel Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 97. Global Food Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Food Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Food Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Pharmaceutical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Pharmaceutical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Pharmaceutical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Technical Grade Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Technical Grade Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Technical Grade Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. Global Binder Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Binder Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Binder Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Controlled Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Controlled Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Controlled Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Emulsion Stabilizer Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Emulsion Stabilizer Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Emulsion Stabilizer Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Suspending Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Suspending Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Suspending Agent Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Viscosity Modification Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Viscosity Modification Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Viscosity Modification Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 123. Global Contract Supply Partners Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Contract Supply Partners Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Contract Supply Partners Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Direct Manufacturer Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Direct Manufacturer Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Direct Manufacturer Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global E Commerce Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global E Commerce Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global E Commerce Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. Global Branded Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Branded Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Branded Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Generic Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Generic Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Generic Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Pharmaceutical Thickener Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. North America Pharmaceutical Thickener Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. North America Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 168. North America Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 169. North America Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 170. North America Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 171. North America Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 172. North America Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 173. North America Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 174. North America Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 175. North America Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 176. North America Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 177. North America Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. North America Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 179. North America Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Latin America Pharmaceutical Thickener Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Latin America Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 182. Latin America Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 183. Latin America Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 184. Latin America Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 185. Latin America Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 186. Latin America Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 187. Latin America Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 188. Latin America Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 189. Latin America Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 190. Latin America Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 191. Latin America Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Latin America Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 193. Latin America Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Europe Pharmaceutical Thickener Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 195. Europe Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 196. Europe Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 197. Europe Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 198. Europe Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 199. Europe Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 200. Europe Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 201. Europe Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 202. Europe Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 203. Europe Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 204. Europe Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 205. Europe Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Europe Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 207. Europe Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. Middle East Pharmaceutical Thickener Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 209. Middle East Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 210. Middle East Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 211. Middle East Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 212. Middle East Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 213. Middle East Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 214. Middle East Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 215. Middle East Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 216. Middle East Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 217. Middle East Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 218. Middle East Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 219. Middle East Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Middle East Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 221. Middle East Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Africa Pharmaceutical Thickener Excipients Market Size, by Region, 2017-2032 (USD Million)
TABLE 223. Africa Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 224. Africa Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 225. Africa Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 226. Africa Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 227. Africa Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 228. Africa Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 229. Africa Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 230. Africa Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 231. Africa Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 232. Africa Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 233. Africa Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Africa Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 235. Africa Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Global Pharmaceutical Thickener Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 237. ASEAN Pharmaceutical Thickener Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 238. ASEAN Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 239. ASEAN Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 240. ASEAN Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 241. ASEAN Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 242. ASEAN Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 243. ASEAN Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 244. ASEAN Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 245. ASEAN Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 246. ASEAN Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 247. ASEAN Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 248. ASEAN Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 249. ASEAN Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 250. ASEAN Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. GCC Pharmaceutical Thickener Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 252. GCC Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 253. GCC Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 254. GCC Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 255. GCC Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 256. GCC Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 257. GCC Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 258. GCC Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 259. GCC Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 260. GCC Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 261. GCC Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 262. GCC Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 263. GCC Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 264. GCC Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. European Union Pharmaceutical Thickener Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 266. European Union Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 267. European Union Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 268. European Union Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 269. European Union Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 270. European Union Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 271. European Union Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 272. European Union Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 273. European Union Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 274. European Union Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 275. European Union Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 276. European Union Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. European Union Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 278. European Union Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. BRICS Pharmaceutical Thickener Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 280. BRICS Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 281. BRICS Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 282. BRICS Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 283. BRICS Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 284. BRICS Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 285. BRICS Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 286. BRICS Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 287. BRICS Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 288. BRICS Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 289. BRICS Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 290. BRICS Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. BRICS Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 292. BRICS Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. G7 Pharmaceutical Thickener Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. G7 Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 295. G7 Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 296. G7 Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 297. G7 Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 298. G7 Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 299. G7 Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 300. G7 Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 301. G7 Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 302. G7 Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 303. G7 Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 304. G7 Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 305. G7 Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 306. G7 Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. NATO Pharmaceutical Thickener Excipients Market Size, by Group, 2017-2032 (USD Million)
TABLE 308. NATO Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 309. NATO Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 310. NATO Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 311. NATO Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 312. NATO Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 313. NATO Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 314. NATO Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 315. NATO Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 316. NATO Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 317. NATO Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 318. NATO Pharmaceutical Thickener Excipients Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. NATO Pharmaceutical Thickener Excipients Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 320. NATO Pharmaceutical Thickener Excipients Market Size, by End User, 2017-2032 (USD Million)
TABLE 321. Global Pharmaceutical Thickener Excipients Market Size, by Country, 2017-2032 (USD Million)
TABLE 322. United States Pharmaceutical Thickener Excipients Market Size, 2017-2032 (USD Million)
TABLE 323. United States Pharmaceutical Thickener Excipients Market Size, by Chemical Class, 2017-2032 (USD Million)
TABLE 324. United States Pharmaceutical Thickener Excipients Market Size, by Cellulosic Derivatives, 2017-2032 (USD Million)
TABLE 325. United States Pharmaceutical Thickener Excipients Market Size, by Inorganic Thickeners, 2017-2032 (USD Million)
TABLE 326. United States Pharmaceutical Thickener Excipients Market Size, by Natural Polysaccharides, 2017-2032 (USD Million)
TABLE 327. United States Pharmaceutical Thickener Excipients Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 328. United States Pharmaceutical Thickener Excipients Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 329. United States Pharmaceutical Thickener Excipients Market Size, by Oral Liquid, 2017-2032 (USD Million)
TABLE 330. United States Pharmaceutical Thickener Excipients Market Size, by Topical, 2017-2032 (USD Million)
TABLE 331. United States Pharmaceutical Thickener Excipients Market Size, by Form, 2017-2032 (USD Million)
TABLE 332. United States Pharmaceutical Thickener Excipients Market Size, by Product Grade, 2017-2032 (USD Million)
TABLE 333. United States Pharmaceutical Thickener Excipients Market Size, by Applicatio

Companies Mentioned

  • ABITEC Corporation
  • Akzo Nobel N.V.
  • Archer Daniels Midland Company
  • Ashland Global Holdings Inc.
  • Ashland Inc.
  • BASF SE
  • Clariant AG
  • Colorcon Inc.
  • CP Kelco
  • Croda International Plc
  • DFE Pharma GmbH & Co. KG
  • DuPont de Nemours, Inc.
  • Elementis Plc
  • Evonik Industries AG
  • Gattefossé SAS
  • Ingredion Incorporated
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH + Co. KG
  • Kerry Group P.L.C.
  • Merck KGaA
  • Roquette Frères S.A.
  • Shin-Etsu Chemical Co., Ltd.
  • SPI Pharma Inc.
  • Sumitomo Seika Chemicals Company, Limited
  • The Lubrizol Corporation